• BRAVECTO logo

1 DOSE. 12* WEEKS OF FLEA AND TICK PROTECTION FOR YOUR CAT.

Diagram of BRAVECTO® VS THE COMPETITION<

BRAVECTO protects your cat nearly 3 times longer than any monthly treatment.
By prescription only at your vet.

Easy—a topical solution with an easy Twist'n'Use™ applicator. Longer lasting. Fewer treatments. Less hassle for your cat.

SEE IF YOUR VET CARRIES BRAVECTO®

By prescription only. Enter your ZIP code to see which veterinarians carry BRAVECTO. Start protecting your pet today.

FDA APPROVED

Safety Icon Plus

The FDA has approved topical Bravecto as safe and effective for cat and kittens at least 6 months old and weighing at least 2.6 pounds.3

VET RECOMMENDED

Safety Icon Plus

Giving BRAVECTO to their own pets shows just how much veterinarians trust it.

"Being a cat owner myself, I prefer to use a topical product that is going to last 12 weeks.* To me it's a no brainer."

Dr. Romanie Walter
SmartVet, Illinois

“I’ve been really happy with BRAVECTO and very confident with the safety profile it provides.”

&npsp;

Dr. Romanie Walter
SmartVet Mobile Veterinary Service, Illinois

“Just because your cat doesn’t go outdoors, doesn’t mean that the other tenants in your apartment building don’t have pets that go indoors and outdoors, so this is a way to protect not only your home but to protect your cat too.”

View MORE TESTIMONIALS submit your BRAVECTO Testimonial
 
 
 
   
   

I irrevocably grant to Intervet Inc., a subsidiary of Merck & Co., Inc. and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns (collectively, "MERCK ANIMAL HEALTH"), the right to take, record, publish or obtain testimonials or other statements from me (collectively, the "Statements") and use, copy, modify, adapt, distribute, publish, display, exhibit and otherwise publish or display in any media, by any means, methods and technologies now known or hereafter to become known, either in whole or in part, the Statements for commercial and business purposes, including, but not limited to, educational, advertising, marketing and promotional materials.

I agree that no advertisement or other material need be submitted to me for any approval. I further waive any and all rights that I may have over the use, distribution, transfer, display, exhibition or other publication of any Statements, including, without limitation, any right to inspect and/or approve such use, publication, distribution, transfer, display, exhibition or other exploitation so long as such Statements are not substantively altered.

I hereby release and discharge, and agree to release and discharge, MERCK ANIMAL HEALTH and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns from, and shall neither sue nor bring any proceeding against any such parties for, any claim or cause of action, whether now known or unknown, for defamation, violation of any moral rights, invasion of right of privacy, publicity or personality or any similar matter, or based upon or relating to any use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements.

I further agree that MERCK ANIMAL HEALTH has the right to attribute the Statements (or statements in different words which have substantially the same meaning) to me, which is an expression of my personal experience and belief, including, without limitation, the use of my name and image in connection therewith. I further acknowledge that I am to receive no compensation from MERCK ANIMAL HEALTH relating to the use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements as set forth in this Release or the use of my name and/or image in connection therewith.

Nothing herein will constitute any obligation on MERCK ANIMAL HEALTH to make any use of the Statements or use of any of the rights set forth herein.

I represent and warrant that I am over the age of eighteen (18) years and have read and understand the contents of this Release.

 

FIND THE RIGHT BRAVECTO PRODUCT FOR YOUR CAT

How to apply BRAVECTO Topical Solution for Cats

A single dose should be applied to the skin on the back of the neck (separate fur if needed) with the easy Twist'n'Use™ applicator once every 12 weeks.*3

BRAVECTO Topical Solution for Cats

Cats over 27.5 lb. should be administered the appropriate combination of tubes.

How to apply BRAVECTO Topical Solution for Cats

A single dose should be applied to the skin on the back of the neck (separate fur if needed) with the easy Twist'n'Use™ applicator once every 12 weeks.*3

BRAVECTO Topical Solution for Cats

Cats over 27.5 lb. should be administered the appropriate combination of tubes.

How to apply BRAVECTO Topical Solution for Cats

A single dose should be applied to the skin on the back of the neck (separate fur if needed) with the easy Twist'n'Use™ applicator once every 12 weeks.*3

BRAVECTO Topical Solution for Cats

Cats over 27.5 lb. should be administered the appropriate combination of tubes.

How to apply BRAVECTO Topical Solution for Cats

A single dose should be applied to the skin on the back of the neck (separate fur if needed) with the easy Twist'n'Use™ applicator once every 12 weeks.*3

BRAVECTO Topical Solution for Cats

Cats over 27.5 lb. should be administered the appropriate combination of tubes.

SAVE MORE WITH BRAVECTO

A single BRAVECTO treatment lasts for 12 weeks* compared to other products which must be given every month. That makes BRAVECTO a cost-effective option for keeping your pet protected. But now, you can save even more.

REBATE OFFER

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

BRAVECTO kills fleas and prevents flea infestations for 12 weeks. BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills black-legged ticks for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION
BRAVECTO has not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. BRAVECTO Chew: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

References:
 1. BRAVECTO Chew [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2. BRAVECTO Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3. BRAVECTO Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 4. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 5. Freedom of Information Summary, NADA 141-459. Approved July 20, 2016. 6. Lavan et al. J Vet Sci Technol. 2017;8:439. 7. Dryden et al. Parasites & Vectors. 2015;8:364. 8. Dryden et al. Parasites & Vectors. 2018;11:422. 9. Burgio et al. Parasites & Vectors. 2016;9:626. 10. CAPC website, Guidelines–Ticks. Available at www.capcvet.org/guidelines/ticks/. Updated April 2017. Accessed December 20, 2018. 11. Walther et al. Parasites & Vectors. 2014;7:86. 12. Walther et al. Parasites & Vectors. 2014;7:481.

Buy Bravecto